Spyre Therapeutics Inc. (SYRE) stock news · $7.60B cap
Spyre Therapeutics Inc. (SYRE) is a biotechnology company listed on NASDAQ.
This SYRE news page leads with what Spyre Therapeutics Inc. filed — not a scraped headline mill.
No cached 8-K sentence for SYRE yet. We will not pad this page with generic market recap.
Latest reported SYRE revenue for 2025-12-31 was $0. Net income was -$155.2M. SYRE currently screens at market cap $7.60B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the SYRE stock page; for the tape open the quote page.
SYRE stock news FAQ
What is SYRE's latest net income?
Latest cached Spyre Therapeutics Inc. (SYRE) net income was -$155.2M. Statements: https://lician.com/financials/syre
What is SYRE's market cap?
Spyre Therapeutics Inc. (SYRE) market cap is $7.60B on the latest cached fundamentals snapshot.
What kind of company is SYRE?
Spyre Therapeutics Inc. (SYRE) is a biotechnology company listed on NASDAQ.
Where is SYRE stock news listed?
Cached stock news for Spyre Therapeutics Inc. (SYRE) is listed at https://lician.com/news/syre. Filings: https://lician.com/sec/syre
Not investment advice.